85.93
Spdr Biotech Etf stock is traded at $85.93, with a volume of 9.32M.
It is up +0.32% in the last 24 hours and up +3.43% over the past month.
See More
Previous Close:
$85.66
Open:
$84.83
24h Volume:
9.32M
Relative Volume:
0.86
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-1.92%
1M Performance:
+3.43%
6M Performance:
-7.27%
1Y Performance:
-12.91%
Spdr Biotech Etf Stock (XBI) Company Profile
Name
Spdr Biotech Etf
Sector
Industry
Phone
-
Address
-
Compare XBI with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
XBI
Spdr Biotech Etf
|
85.93 | 0 | 0 | 0 | 0 | 0.00 |
![]()
VTI
Vanguard Total Stock Market Etf
|
305.74 | 417.53B | 0 | 0 | 0 | 0.00 |
![]()
SPY
Spdr S P 500 Etf Trust
|
621.72 | 372.57B | 0 | 0 | 0 | 0.00 |
![]()
IVV
Ishares Core S P 500 Etf
|
624.65 | 253.41B | 0 | 0 | 0 | 0.00 |
![]()
VB
Vanguard Small Cap Etf
|
237.58 | 160.59B | 0 | 0 | 0 | 0.00 |
![]()
QQQ
Invesco Qqq Trust Series 1
|
553.88 | 124.43B | 0 | 0 | 0 | 0.00 |
Spdr Biotech Etf Stock (XBI) Latest News
SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by LPL Financial LLC - Defense World
N.E.W. Advisory Services LLC Acquires New Stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
Lyell Wealth Management LP Has $1.18 Million Stock Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
Biotech Has Been Stalling. 3 Stocks That Could See Healthy Gains. - MSN
XBI: Surprise Exit Of A Tough Regulator At The FDA (NYSEARCA:XBI) - Seeking Alpha
Letko Brosseau & Associates Inc. Has $3.24 Million Stock Position in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
Cetera Investment Advisers Buys 5,604 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
IFP Advisors Inc Decreases Stock Position in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
6 Best Health Care Funds and ETFs for 2025 | Investing - Money/ US News
(XBI) Trading Advice - news.stocktradersdaily.com
SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Purchased by Cerity Partners LLC - Defense World
Cerity Partners LLC Has $1.51 Million Stock Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
Envestnet Asset Management Inc. Sells 16,015 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
M&T Bank Corp Has $446,000 Stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
SPDR S&P Biotech ETF (NYSEARCA:XBI) Stake Lowered by Stratos Wealth Partners LTD. - Defense World
SPDR S&P Biotech ETF Options Spot-On: On July 15th, 99,099 Contracts Were Traded, With 717.92K Open Interest - 富途牛牛
Biotech Stocks Are Ready to Rebound. Gilead Sciences and 2 More to Watch Now. - Barron's
XBI ETF: Riding the Pharma-Biotech Consolidation Wave - AInvest
Biotech Stocks Are Ready to Rebound. 3 to Watch Now. - Barron's
(XBI) Investment Analysis and Advice - news.stocktradersdaily.com
Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now? - Yahoo Finance
Biotech ETFs: Navigating Growth and Stability in a Volatile Landscape - AInvest
Biotech Looks Ready To Run, But ETFs, Which One? IBB Vs. XBI - Seeking Alpha
How to Take Advantage of moves in (XBI) - news.stocktradersdaily.com
Notable ETF Outflow DetectedXBI, INSM, ALNY, BPMC - Nasdaq
Learn to Evaluate (XBI) using the Charts - news.stocktradersdaily.com
Dynamic Advisor Solutions LLC Takes $825,000 Position in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
3,309 Shares in SPDR S&P Biotech ETF (NYSEARCA:XBI) Bought by Park Avenue Securities LLC - Defense World
SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Purchased by GAMMA Investing LLC - Defense World
Should You Invest in the SPDR S&P Biotech ETF (XBI)? - sharewise
Long Term Trading Analysis for (XBI) - news.stocktradersdaily.com
Should You Invest in the iShares Biotechnology ETF (IBB)? - sharewise
How Is Vertex Pharmaceuticals’ Stock Performance Compared to Other Biotech Stocks? - The Globe and Mail
Northern Trust Corp Reduces Position in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)? - Nasdaq
Hedge Funds Question Market Rally, Build Massive Short WallAmer Sports (NYSE:AS), First Solar (NASDAQ:FSLR) - Benzinga
Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now? - Nasdaq
Novavax Scores Key FDA Win, Shares Jump 19% As Sanofi Unlocks Milestone Payment - Benzinga
Zacks Investment Ideas feature highlights: Alibaba, JD.com, SPDR S&P Biotech ETF, Merck and Microsoft - TradingView
XBI: Some Tariff Relief Right Now, But Macro Risks Remain In Biotech (NYSEARCA:XBI) - Seeking Alpha
Optimism is Back for Biotech Stocks. This Time, It Could Last. - MSN
MBB Leads With $1.2B Gain as Markets React to UK Trade Deal - TradingView
XBI, EXAS, ALNY, NTRA: Large Outflows Detected at ETF - Nasdaq
(XBI) Investment Analysis - news.stocktradersdaily.com
XBI, Biotech Stocks Retreat: Buy, Hold or Sell? - ETF.com
Vinay Prasad's Appointment To FDA's CBER Triggers Questions Over Future Of Cell And Gene Therapy Regulation - Benzinga
SPDR S&P Biotech ETF Target of Unusually High Options Trading (NYSEARCA:XBI) - Defense World
SPDR S&P Biotech ETF Options Spot-On: On May 6th, 140.63K Contracts Were Traded, With 658.97K Open Interest - 富途牛牛
Optimism Is Back for Biotech Stocks. This Time, It Could Last. - Barron's
Spdr Biotech Etf Stock (XBI) Financials Data
There is no financial data for Spdr Biotech Etf (XBI). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):